Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_assertion description "[In this study, we investigated the prognostic value of CTC/CSC that express carcinoembryonic antigen (CEA) cytokeratin 19 (CK19), CK20 and/or CD133 (CEA/CK/CD133) mRNA in the tumor drainage blood of CRC patients with Dukes' stage B and C. We examined tumor drainage blood from 197 patients with Dukes' stage B and C CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_assertion evidence source_evidence_literature NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_assertion SIO_000772 22267181 NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_assertion wasDerivedFrom befree-20140225 NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_assertion wasGeneratedBy ECO_0000203 NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP192337.RABLueJhuyRzObZ2RWdi1NCAOpYW6Fh-PEMR-GW8-VdrM130_provenance.